Stay updated with breaking news from Exceed full year. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Revenues in the First Quarter 2022 Already Exceed Full-Year 2021 Revenues.Revenue Development Fueled by Sono Solar B2B Customer Projects.Solar Business Expansion With 5 New B2B Partnerships in. | June 22, 2022 ....
Revenues in the First Quarter 2022 Already Exceed Full-Year 2021 Revenues.Revenue Development Fueled by Sono Solar B2B Customer Projects.Solar Business. ....
Press release content from Globe Newswire. The AP news staff was not involved in its creation. Interpace Biosciences Announces First Quarter 2021 Financial and Business Results Interpace Biosciences, Inc.May 11, 2021 GMT
● Q1 Revenue of $9.8 Million is Company’s Highest as Combined Molecular Diagnostics and Pharma Services Business
ADVERTISEMENT PARSIPPANY, NJ, May 11, 2021 (GLOBE NEWSWIRE) Interpace Biosciences, Inc. (“Interpace” or the “Company”) (OTCQX: IDXG) today announced financial results for the fiscal quarter ended March 31, 2021 and provided a business and financial update. “We are very pleased with our first quarter operating results which are on track and in accordance with our growth, restructuring and reprioritization plan,” said President and CEO Thomas Burnell. “As we progress further into 2021, we expect to build on this momentum and will be focused on opportunities related to expanded pri ....